Show simple item record

Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma

dc.contributor.authorGurnell, Mark
dc.contributor.authorDomingo, Christian
dc.contributor.authorRabe, Klaus F
dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorPrice, David
dc.contributor.authorBrusselle, Guy
dc.contributor.authorWechsler, Michael E
dc.contributor.authorXia, Changming
dc.contributor.authorPandit-Abid, Nami
dc.contributor.authorGall, Rebecca
dc.contributor.authorJacob-Nara, Juby A.
dc.contributor.authorRowe, Paul J.
dc.contributor.authorDeniz, Yamo
dc.contributor.authorSiddiqui, Shahid
dc.date.accessioned2023-11-30T00:13:00Z
dc.date.available2023-11-30T00:13:00Z
dc.date.issued2022-11-30
dc.identifier217236354
dc.identifierab934c96-cda8-4107-93e5-24ceedb73f4c
dc.identifier.citationGurnell , M , Domingo , C , Rabe , K F , Menzies-Gow , A , Price , D , Brusselle , G , Wechsler , M E , Xia , C , Pandit-Abid , N , Gall , R , Jacob-Nara , J A , Rowe , P J , Deniz , Y & Siddiqui , S 2022 , ' Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma ' , European Respiratory Society (ERS) International Congress. , Barcelona , Spain , 4/09/22 - 6/09/22 .en
dc.identifier.citationconferenceen
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19972
dc.format.extent163872
dc.language.isoeng
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleDupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthmaen
dc.typeConference itemen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.date.embargoedUntil2023-11-30


Files in this item

Thumbnail
Name:
Gurnell_etal_ERS2022_Dupilumab ...
Size:
160.0Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record